Cell therapy specialist Sino-Biocan has completed a nearly 100 million yuan ($15 million) Series A round of financing led by Far East Horizon’s venture unit Grand Flight Investment.
Continue reading with Data Vantage
Venture-backed company data in SE Asia, India, Pakistan, Bangladesh.
Instant investment updates and valuations.
Tailored search, 3 monthly reports.
Industry-trusted platform.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
